The present invention relates to peptides which interact with IAPs. IAPs
are highly expressed in tumor cells which fail to undergo apoptosis. By
binding to IAPs, the peptides of the present invention release tumor
cells from the apoptosis block and thus provide a new tool for effective
cancer therapy.